Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Barchart

Lawsuits Filed Against Abbott Nutrition Over Infant Formula Contamination

Lawsuit filed against Abbott Nutrition over tainted infant formula linked to baby's death, raising awareness about powdered formula risks.

Top News

After baby's death, Kentucky parents sue infant formula maker at center of 2022 crisis

The parents of Kentucky baby who died last fall after drinking bacteria-tainted infant formula are the latest to sue manufacturer Abbott Nutrition

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Reckitt Benckiser’s shares slump after Abbott baby formula ruling over bowel disease link

British group says claims products cause serious bowel condition NEC are ‘not supported by science’

The Guardian - UK

Abbott Warns Of Potential Inaccuracies In Blood Sugar Monitoring Sensors

Abbott issues warning about potential inaccuracies in FreeStyle Libre 3 blood sugar sensors, offering free replacements for affected devices.

Top News

Abbott warns that some of its blood sugar monitors may need replacement due to incorrect readings

Abbott is warning that sensors on some of its blood sugar monitoring systems may need to be replaced to prevent inaccurate readings

The Independent UK

3 Highest-yielding Dividend Aristocrats With Strong-buy Ratings

Discover the top three highest-rated, highest-yielding Dividend Aristocrats for your retirement portfolio.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Abbott's Q2 2024 Earnings: What to Expect

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

Barchart

3 Top S&P 500 Stocks With Strong Analyst Ratings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

StockNews.com

FDA took months to react to complaint about Abbott infant formula factory, audit finds

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

The Independent UK

How Is Abbott's Stock Performance Compared to Other Medical Devices Stocks?

Despite Abbott’s recent underperformance over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

Barchart

Volatility halts hit numerous NYSE-listed stocks in error

An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open in about a dozen companies, including Chipotle Mexican Grill Inc. and Abbott Laboratories.

Evening Standard

Abbott Stock: Analyst Estimates & Ratings

Abbott has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.

Barchart

12 things I am buying in the Memorial Day sales that make my patio look more expensive for under $300

Sprucing up your backyard for summer can be an expensive endeavor, but not with these deals

Homes & Gardens

Get all your
news in one place.

100's of premium titles.
One news app.

Homes & Gardens

Pottery Barn deals − how to get the biggest saving on seasonal collections and accent pieces

Here's everything you need to know about what to shop and how to save in the Pottery Barn sales, according to our expert team of eCommerce Editors

WhatToWatch

The Young and the Restless spoilers: Devon teams up with someone shocking in battle against Billy?

The Young and the Restless’ Billy continues to stir the pot at Chancellor-Winters. Will his antics push Devon to work with an unlikely partner?

Top News

Abbott Exceeds Profit Expectations With Strong Medical Device Sales

Abbott Laboratories surpasses profit expectations with strong medical device sales, showcasing market leadership and growth strategies.

TechRadar

I tried Abbott’s new CGM Lingo for two weeks, and here’s what I learned

5 things you need to know about Lingo, the new smart continuous glucose monitor.

Get all your
news in one place.

100's of premium titles.
One news app.

WhatToWatch

Why aren't The Conners, Not Dead Yet and Abbott Elementary new tonight, April 3?

For the second week in a row, The Conners, Not Dead Yet and Abbott Elementary are airing reruns in place of new episodes. Here's what we know.

Top News

Abbott's Heart Valve Repair Device Receives US Approval

Abbott's ABBOTT-HEART device gains US approval, offering minimally invasive heart valve repair solution, revolutionizing heart care.

Barchart

3 Passive Income Stocks To Scoop Up Now

These three stocks have earned the title of Dividend Kings by consistently increasing dividends for at least 50 years.

Salon

U.S. govt protected baby formula makers

The U.S. government repeatedly used its muscle to advance the interests of large baby formula companies

TechRadar

Continuous glucose monitors – health fad or the future of wellbeing?

Over the past couple of years, interest in direct-to-consumer applications for continuous glucose monitoring has spiked, but not every expert is convinced these medical devices have a place in the arms of regular, non-diabetic folk.

Kiplinger

SECURE 2.0 Act Now Helps Lighten the Burden of Student Loans

Employers can attract talented employees with a new benefit: a matching contribution to an employees’ 401(k) when they make payments on their student debt.

International Business Times

10 Best Technology Brands At CES 2024

The final list is not just a win for consumers on the lookout for groundbreaking tech but also serves as an eye-opener to investors searching for scalable tech solutions poised for global impact.

1 … 4 5 6 7

People

Ashley Eileen Davidson

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.